Liver transplantation in autoimmune liver disease - Selection of patients

Hepato-Gastroenterology

Volumn 46, Issue 30, 1999, Pages 3053-3059

  Tillmann, Hans L ^b   Jäckel, Elmar ^b   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Autoimmune liver disease; Prognostic models; Transplantation

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; URSODEOXYCHOLIC ACID;

AUTOIMMUNE HEPATITIS; BILE DUCT CARCINOMA; CANCER RISK; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; SURVIVAL TIME;

CHOLANGITIS, SCLEROSING; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; PATIENT SELECTION; PROGNOSIS;

EID: 0032804024     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. 1 Manns MP: Recent developments in autoimmune liver diseases. J Gastroenterol Hepatol 1997 Oct; 12(9-10):S256-S271.
2. 2 Manns MP, Obermayer-Straub P: Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 1997; 26:1054-1066.
3. 3 Manns M, Gerken K, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH: Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against soluble liver antigen. Lancet 1987; 1:292-294.
4. 4 Johnson PJ, McFarlane IG, Alvarez F, Bianchi FG, Bianchi L, Burroughs A, Chapman RW, et al: Meeting Report: International Autoimmune Hepatitis Group. Hepatology 1993; 18:998-1005.
5. 5 Roberts SK, Therneau TM, Czaja AJ: Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996; 110: 848-857.
6. 6 Gregorio GV, Portman B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP et al: Autoimmune hepatitis in childhood: A 20 year experience. Hepatology 1997: 25:541-547.
7. 7 Cook GC, Mulligan R, Sherlock S: Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971; 40:159.
8. 8 Combes B, Maddrey WC: Therapy of idiopathic autoimmune chronic active hepatitis. In: Immunology of the liver: Proceeding of the Falk Symposium 1970 held in Basel, Switzerland. Meyer zum Büschenfelde KH, Hoofnagle J, Manns MP (Eds.). Dordrecht: Kluwer Academic Publishers 1993; pp. 250-256.
9. 9 Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Association between a alleles of the major histocompatibility complex in autoimmune hepatitis. Hepatology 1997; 25:317-323.
10. 10 Person JL, McHutchison JG, Fong TL, Redeker AG: A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis. J Clin Gastroenterol 1993; 17:317-320.
11. 11 Schüler A, Manns MP: Treatment of autoimmune hepatitis. In: Arroyo V, Bosch J, Rodez J (Eds.). Treatment in Hepatology. Barcelona: Masson SA, 1995; pp. 375-383.
12. 12 Vento S, Cainelli F, Renzini C, Ghironzi G, Concia E: Resolution of autoimmune hepatitis after bone marrow transplantation. Lancet 1996; 348:544-545.
13. 13 Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, et al: Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national Conference organized by the American Society of Transplant Physicians and the American Association of the Study of Liver Disease. Liver Transplant and Surgery 1997; 3:628-637.
14. 14 Wright HL, Bou-Abboud C, Hassanein T, Block GD, Demetris AJ, Starzl TE, Van Thiel DH: Disease recurrence following liver transplantation for autoimmune chronic liver disease. Transplantation 1992; 53:136-139.
15. 15 Birnbaum AH, Benkov KJ, Pittman NS, McFarlane-Ferreira Y, Rosh JR, LeLeiko NS: Recurrence of autoimmune hepatitis in children after liver transplantation. J Pediatr Gastroenterol Nutr 1997; 25:20-25.
16. 16 Chenard-Neu MP, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, Costes V, et al: Auxilliar liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure - a multicenter European study. Hepatology 1996; 23:1119-1127.
17. 17 Herzog D, Rasquin-Weber AM, Debray D, Alvarez F: Subfulminant hepatic failure in autoimmune hepatitis type 1: An unusual form of presentation. J Hepatol 1997; 27:578-582.
18. 18 Knoop M, Bechstein WO, Schrem H, Lobeck H, Hopf U, Neuhaus P: Clinical significance of recurrent primary biliary cirrhosis after liver transplantation. Transpl Int 1996; 9(Suppl 1):S115-S119.
19. 19 Keiding S, Ericzon BG, Eriksson S, Flatmark A, Hockerstedt K, Isoniemi H, Karlberg I, et al: Survival after liver transplantation of patients with primary biliary cirrhosis in the Nordic countries. Comparison with expected survival in another series of transplantations and in an international trial of medical treatment. Scand J Gastroenterol 1990; 25:11-18.
20. 20 Shapiro JM, Smith H, Schaffner F: Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20:137-140.
21. 21 Roll J, Boyer JL, Barry D, Klatskin G: The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308:1-7.
22. 22 Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R: Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology 1985; 89: 1084-1091.
23. 23 Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A: Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10:1-7.
24. 24 Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL: Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 1989; 10:846-850.
25. 25 Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R: Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology 1993; 105:1865-1876.
26. 26 Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R: Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology 1992; 16:1404-1408.
27. 27 Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME: Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens 1994; 43:71-77.
28. 28 Klein R, Kloppel G, Garbe W, Fintelmann V, Berg PA: Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years. J Hepatol 1991; 12:21-27.
29. 29 Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, Krom RA: Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992; 16:1290-1299.
30. 30 Consensus statement on indications for liver transplantation: Paris, June 22-23, 1993: Hepatology 1994; 20:63S-68S.
31. 31 Broome U, Eriksson LS: Assessment for liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1994; 20:654-659.
32. 32 Helzberg JH, Petersen JM, Boyer JL: Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987; 92:1869-1875.
33. 33 Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10:430-436.
34. 34 Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100:1710-1717.
35. 35 Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM, et al: Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103:1893-1901.
36. 36 Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, Theilmann L: Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study, J Hepatol 1997; 26:560-566.
37. 37 Wagner S, Gebel M, Meier P, Trautwein C, Bleck J, Nashan B, Manns MP: Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 1996; 28:546-551.
38. 38 Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar K, Welsh KI, Eddleston ALWF, Williams R: Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility and protection from primary sclerosing cholangitis. Hepatology 1992; 16:390-395.
39. 39 Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, Pichlmayr R: Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996; 23:1105-1111.
40. 40 Delcore R, Eisenach JB, Payne KM, Bhatia P, Forster J: Risk of occult carcinomas in patients undergoing orthotopic liver transplantation for end-stage liver disease secondary to primary sclerosing cholangitis. Transplant Proc 1993; 25:1883-1884.
41. 41 Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL: Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22:451-457.
42. 42 Stephens J, Goldstein R, Crippin J, Husberg B, Holman M, Gonwa TA, Klintmalm G: Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc 1993; 25:1122-1123.
43. 43 Bleday R, Lee E, Jessurun J, Heine J, Wong WD: Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36:908-912.